D-180-2013 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Bridgewater, NJ

FDA drug recall D-180-2013 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 1, 2012 and is designated Class II. Reason for recall: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell. The recall status is terminated (terminated May 24, 2013). Affected quantity: 48, 754 bottles (C108376)/47,520 bottles (C108634).

Recall details

Product Type
Drugs
Report Date
Mar 6, 2013
Initiation Date
Aug 1, 2012
Termination Date
May 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
48, 754 bottles (C108376)/47,520 bottles (C108634)

Product description

Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30

Reason for recall

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Distribution pattern

Nationwide

Code information

Lot #: C108376, C108634, Exp 11/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-180-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-180-2013. Report a data issue: hello@regdatalab.com.